The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecule Type

Beatriz G. de la Torre; Fernando Albericio

research article

oai:doaj.org/article:bd9d910293d449d9813cb0d6fcb56e84

The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecule Type

Authors: Beatriz G. de la Torre
Fernando Albericio
Publication date: 1 February 2017
Publisher: 'MDPI AG'
Doi

Abstract

This is an analysis from a chemical point of view of the 22 drugs accepted by the FDA during 2016. The different drugs from the 2016 “harvest” have been classified according to their chemical structure: antibodies; TIDES (oligonucleotides and peptides); amino acids and natural products; drug combination; and small molecules

Similar works

Full text

Directory of Open Access Journals

oai:doaj.org/article:bd9d91029...

Last time updated on 13/10/2017

This paper was published in Directory of Open Access Journals.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.